Quality is at the forefront of Penn's operations and we are committed to delivering services that meet and exceed your expectations. At Penn, we operate an ISO based, mature quality management system which is regularly inspected by both the Medicines and Healthcare Products Regulatory Agency (MHRA) and the United States Food and Drug Administration (FDA).
With the advent of the new European Clinical Trials Directive (2001/20/EC), in May 2004 Penn were one of the first companies to obtain the new MA-IMP licence. Penn also hold the following licences:

• MHRA Manufacturer’s and Importers Licence (No. MIA 4351).
• MHRA Manufacturer’s Special’s Licence (No: MS 4351).
• MHRA Wholesale Dealers Licence (No: WL/4351/01).
• MHRA Manufacturer Investigation Medicial Products Licence (No. MA [IMP] 4351).
• Home Office Controlled Drugs (Narcotics) Licence.
• Registered with the FDA as an assembler of medical devices.

Additionally we welcome and host in excess of 50 client and regulatory body audits annually which reassures our clients that Penn operates to the highest possible standards.

For more information, read our Company Quality Policy